Heng A. Zhang
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evaluation of the Potential Targets of Shenxian-Shengmai Oral Liquid in Treating Sick Sinus Syndrome Based on Network Pharmacology and Molecular Docking.
Journal: Food science & nutrition
Published: March 29, 2024
Linkages of soil CO2 emission with plant functional traits in young subtropical plantations.
Journal: Ying yong sheng tai xue bao = The journal of applied ecology
Published: November 24, 2023
Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: August 06, 2022
NRF-2/HO-1 Pathway-Mediated SHOX2 Activation Is a Key Switch for Heart Rate Acceleration by Yixin-Fumai Granules.
Journal: Oxidative medicine and cellular longevity
Published: April 22, 2022
Yixin-Fumai granules improve sick sinus syndrome in aging mice through Nrf-2/HO-1 pathway: A new target for sick sinus syndrome.
Journal: Journal of ethnopharmacology
Published: April 14, 2021
Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: January 21, 2021
The Effect of Ginsenoside RB1, Diazoxide, and 5-Hydroxydecanoate on Hypoxia-Reoxygenation Injury of H9C2 Cardiomyocytes.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: September 12, 2019
The interrelationship between cholinergic pathway in the magnocellular paraventricular nucleus and natriuresis.
Journal: General physiology and biophysics
Published: September 26, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026